Prognostic evaluation of CD44 expression in correlation with bcl-2 and p53 in colorectal cancer

Folia Histochemica et Cytobiologica

Volumn 43, Issue 1, 2005, Pages 31-36

  Zavrides, H N ^a   Zizi Sermpetzoglou, A ^a   Panousopoulos, D ^b   Athanasas, G ^b   Elemenoglou, I ^a   Peros, G ^b  

^a TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Bcl 2; CD44; Colorectal cancer; P53; Prognosis

Indexed keywords

HERMES ANTIGEN; PROTEIN BCL 2; PROTEIN P53;

AGED; ARTICLE; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION;

EID: 14844332038     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Abbasi AM, Chester KA, Talbot IC, Macpherson AS, Boxer G, Forbes A, Malcolm ADB, Begent RH (1993) CD44 is associated with proliferation in normal and neoplastic human colorectal epithelial cells. Eur J Cancer 29A: 1995-2002
2. Azanovoorian S, Murphy AN, Stetler-Stevenson WG, Liotta LA (1993) Molecular aspects of tumour invasion and metastasis. Cancer 71: 1368-1383
3. Barshishat M, Levi I, Benharroch D, Schwartz B (2002) Butyrate down-regulates CD44 transcription and liver colonisation in a highly metastatic human colon carcinoma cell line. Br J Cancer 87: 1314-1320
4. Bendardaf R, Ristamaki R, Kujari H, Laine J, Lamlum H, Collan Y, Pyrhonen S (2003) Apoptotic index and bcl-2 expression as prognostic factors in colorectal carcinoma. Oncology 64:435-442
5. Bhatavdekar JM, Patel DD, Chikhlikar PR, Shah NG, Vora HH, Ghosh N, Trivedi TI (2001) Molecular markers are predictors of recurrence and survival in patients with Dukes B and Dukes C colorectal adenocarcinoma. Dis Colon Rectum 44: 523-533
6. Carr NJ, Emory TS, Sobin LH (2002) Epithelial neoplasms of the appendix and colorectum: an analysis of cell proliferation, apoptosis and expression of p53, CD44 and bcl-2. Arch Pathol Lab Med 126: 837-841
7. Choi SH, Takabashi K, Eto H, Yoon SS, Tanabe KK (2000) CD44 expression in human colon carcinomas influences growth of liver metastases. Int J Cancer 85: 523-526
8. Coppola D, Hyacinthe M, Fu L, Cantor AB, Karl R, Marcet J, Cooper DL, Nicosia SV, Cooper HS (1998) CD44V6 expression in human colorectal carcinoma. Hum Pathol 29: 627-635
9. Dall P, Heider KH, Sinn HP, Skroch-Angel P, Adolf G, Kaufmann M, Herrlich P, Ponta H (1995) Comparison of immunohistochemistry and RT-PCR for detection of CD44v expression, a new prognostic factor in human breast cancer. Int J Cancer 60: 471-477
10. Garrity MM, Burgart LJ, Mahoney MR, Windschitl HE, Salim M, Wiesenfeld M, Krook JE, Michalak JC, Goldberg RM, O'Connell MJ, Furth AF, Sargent DJ, Murphy LM, Hill E, Riehle DL, Meyers CH, Witzig TE; North Central Cancer Treatment Group (2004) Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group study. J Clin Oncol 22: 1572-1582
11. Gotley DC, Fawvrtt J, Walsh MD, Reeder JA, Simmons D, Antalis TM (1996) Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer. Br J Cancer 74: 342-351
12. Haier J, Nasralla M, Nicolson GL (2000) Cell surface molecules and their prognostic values in assessing colorectal carcinomas. Ann Surg 237: 11-24
13. Haseba M, Hidaka S, Tsuji T, Yano H, Komatsu H, Sawai T, Yasutake T, Nakagoe T, Tagawa Y, Ayabe H (2003) Detection of p53 gene mutations by nonisotopic RNase cleavage assay as a predictor of poor prognosis in colorectal cancers. Dig Dis Sci 48: 1984-1989
14. Heider KH, Hoffman M, Hors E, van den Berg F, Ponta H, Herlich P, Pals ST (1993) A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 120: 227-233
15. Ikeda S, Shimizu Y, Fujimori M, Ishizaki Y, Kurihara T, Ojima Y, Okajima M, Asahara T (2003) Immunohistochemical and mutational analyses of beta-catenin Ki-ras, and p53 in two subtypes of colorectal mucinous carcinoma. Clin Cancer Res 9: 5660-5665
16. Indinnimeo M, Cicchini C, Giarnieri E, Stazi A, Mingazzini PL, Stipa V (2003) Evaluation of CD44 variant 6 expression and clinicopathological factors in pulmonary metastases from colon carcinoma. Oncol Rep 10: 1875-1877
17. Ishida T (2000) Immunohistochemical expression of CD44 variant 6 in colorectal adenocarcinoma. Surg Today 30: 28-32
18. Jalkanen S, Bargatze RE, de los Toyos J, Butcher EC (1987) Cell surface proteoglycan of mouse mammary epithelial cell is shed by cleavage of its matrix-binding ectodomain from its membrane-associated domain. J Cell Biol 105: 983-990
19. Jungling B, Menges M, Goebel R, Wittig BM, Weg-Remers S, Pistorius G, Schilling M, Bauer M, Konig J, Zeitz M, Stallmach A (2002) Expression of CD44v6 has no prognostic value in patients with colorectal cancer. Z Gastroenterol 40: 229-233
20. Kahlenberg MS, Stoler DL, Rodriguez-Bigas MA, Weber TK, Driscoll DL, Aderson GR, Petrelli NJ (2000) P53 tumour suppressor gene mutations predict decreased survival of patients with sporadic colorectal carcinoma. Cancer 88: 1814-1819
21. Kerr JF, Winterford CM, Harmon BV (1994) Apoptosis; its significance in cancer and cancer therapy. Canc er 73: 2013-2026
22. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B, Clevers H (1997) Constitutive transcriptional activation by a beta-catenin-Tc complex in APC-/-colon carcinoma. Science 275: 1784-1787
23. Kouraklis G, Kakisis J, Theoharis S, Tzonou A, Glinavou A, Raftopoulos J, Karatzas G (2003) Prognostic significance and correlation with survival of bcl-2 and TGF-beta RII in colon cancer. Dig Dis Sci 48: 2284-2289
24. Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W, Reed JC (1993) Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum and outer mitochondrial membranes. Cancer Res 53: 4701-4714
25. Kuppner MC, Van Meir E, Gauthier T, Hmou MF, de Tripolet N (1992) Differential expression of the CD44 molecule in human brain tumours. Int J Cancer 50: 572-577
26. Matsumura Y, Tarin D (1992) Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 340: 1053-1058
27. Morrin M, Delaney PV (2002) CD44v6 is not relevant in colorectal tumour progression. Int J Colorectal Dis 17: 30-36
28. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kizler KW (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275: 1787-1790
29. Naor D, Sionov RV, Ish-Shalom D (1997) CD44: structure, function, and association with the malignant process. Adv Cancer Res 71: 241-319
30. Oren M (1992) The involvement of oncogenes and tumour suppressor genes in the control of apoptosis. Cancer Metastasis Rev 11: 141-148
31. Pricolo VE, Finkelstein SD, Hansen K, Cole BF, Bland KI (1997) Mutated p53 gene is an independent adverse predictor of survival in colon carcinoma. Arch Surg 132: 371-375
32. Sun XF, Bartik Z, Zhang H (2003) Bcl-2 expression is a prognostic factor in the subgroups of patients with colorectal cancer. Int J Oncol 23: 1439-1443
33. Tollenaar RA, van Krieken JH, van Slooten HJ, Bruinvels DJ, Nelemans KM, van den Broek LJ, Hermans J, van Dierendonck JH (1998) Immunohistochemical detection of p53 and bcl-2 in colorectal carcinoma: no evidence for prognostic significance. Br J Cancer 77: 1842-1847
34. Viale G (1997) Prognostic and predictive value of p53 aberrations in tumours in the gastrointestinal tract and pancreas. In: Prognostic and predictive value of p53. Vol I, Klijn JGM [Ed], ESO Scientific Updates, Elsevier, Amsterdam, pp 131-141
35. Visca P, Del Nonno F, Botti C, Marandino F, Sebastiani V, Di Tondo U, Donnorso RP, Trombetta G, Filippi S, Alo PL (2002) Role and prognostic significance of CD44s expression in colorectal cancer. Anticancer Res 22: 2671-2675
36. World Health Organization (1976) International histological classifications of tumours. No 15. Histological typing of intestinal tumours. WHO, Geneva
37. Zalewski B, Famulski W, Sulkowska M, Sobaniec-Lotowska M, Piotrowski Z, Kisielewski W, Sulkowski S (2001) CD44 expression in colorectal cancer: an immunohistochemical study including correlation with cathepsin D immunoreactivity and some tumour clinicopathological features. Folia Histochem Cytobiol 39, Suppl. 2, 152-153